What are the consequences of missing the scheduled 32‑week anti‑D immunoglobulin (RhIG) dose in an Rh‑negative mother carrying an Rh‑positive fetus?

Missing the 32-Week Anti-D Dose Increases Risk of Maternal Sensitization

If you skip the scheduled 32-week (or 28-week) anti-D immunoglobulin dose in an Rh-negative mother carrying an Rh-positive fetus, you lose critical protection against maternal sensitization that occurs during the third trimester, potentially leading to hemolytic disease in the current or future pregnancies.

The Core Problem

The antenatal anti-D dose at 28-32 weeks exists specifically because approximately 50% of Rh sensitization occurs during pregnancy itself, not just at delivery 1. Without this prophylactic dose, you're leaving the mother vulnerable during the period when transplacental hemorrhage becomes increasingly common (after 28 weeks gestation) 2.

What Happens When You Skip It

Immediate Pregnancy Risk

• The current fetus faces minimal risk since this is typically a first sensitization event
• Antibody production takes time, so severe hemolytic disease in the index pregnancy is uncommon

Future Pregnancy Consequences

• The real danger is to subsequent Rh-positive pregnancies
• Once sensitized, the mother will produce anti-D antibodies that cross the placenta in future pregnancies
• This leads to hemolytic disease of the fetus and newborn (HDFN) with:
  • Fetal anemia
  • Hydrops fetalis
  • Intrauterine death
  • Severe neonatal jaundice requiring exchange transfusion

The Evidence for Antenatal Prophylaxis

The two-dose regimen (antenatal + postpartum) reduces sensitization rates dramatically:

• Postpartum anti-D alone: Reduces sensitization from 12-13% to 1.6-2% 3
• Adding antenatal dose at 28 and 34 weeks: Further reduces sensitization to 0.2-0.4% 4, 5

A key study using 100μg (500 IU) doses at 28 and 34 weeks showed clear benefit, with sensitization rates dropping from 1.5% to 0.2% (OR 0.22,95% CI 0.05-0.88) 5.

Clinical Management If the Dose Was Missed

If Still Pregnant

1. Give the anti-D immediately - better late than never
2. The standard dose is 300μg (1500 IU) intramuscularly 3
3. Still give postpartum anti-D within 72 hours of delivery if the infant is Rh-positive 3

Timing Considerations

• Anti-D is most effective when given within 72 hours of a sensitizing event 3
• However, some protection may persist even with delayed administration
• The postpartum dose remains critical regardless of whether antenatal prophylaxis was given

Postpartum Testing

• Perform Kleihauer-Betke or flow cytometry to quantify fetomaternal hemorrhage
• If >15 mL of fetal RBCs detected, additional anti-D doses are required (one 300μg dose covers approximately 15 mL of fetal RBCs or 30 mL of fetal blood) 3

Common Pitfalls to Avoid

1. Don't assume the postpartum dose alone is sufficient - you've already lost the window for preventing third-trimester sensitization
2. Don't skip antibody screening - check for anti-D antibodies at delivery and in subsequent pregnancies
3. Don't forget to verify infant's Rh status - if the baby is Rh-negative, the postpartum dose isn't needed (but you still missed preventing potential sensitization from an Rh-positive fetus)
4. Don't underdose with large fetomaternal hemorrhage - always quantify the bleed and adjust dosing accordingly 6

Future Pregnancy Monitoring

If sensitization occurred due to the missed dose:

• Cell-free fetal DNA testing should be used early in subsequent pregnancies to determine fetal Rh status 7
• If the fetus is Rh-positive, initiate middle cerebral artery peak systolic velocity Doppler surveillance to detect fetal anemia 7
• Consider intravenous immunoglobulin (IVIG) in select high-risk cases with documented antigen-positive fetuses and prior severe HDFN 7
• Be prepared for intrauterine transfusion if severe fetal anemia develops 7

The Bottom Line

The missed 28-32 week dose represents a lost opportunity for optimal prevention. While postpartum prophylaxis still provides substantial protection, you've accepted a higher baseline risk of sensitization (returning closer to the 1.6% range rather than 0.2%). The mother should be counseled about increased vigilance in future pregnancies, and antibody screening should be performed to detect any sensitization that may have occurred.